Figure 6A shows that invalidation of NLRP7 in JEG-3 cells significantly compromised tumor development in the lungs. Quantification of tumor growth showed that a significant difference was observed from day 28 post-injection. A trend of an increase was also observed at day 34 post-injection, Figure 6B. This evidence concerns the gene NLRP7 and neoplasm.